Highlights

  • Grindr agreed to acquire PurposeMed for cash and shares, with additional cash consideration tied to future performance targets.
  • Both boards approved the proposed transaction, but completion remains subject to customary conditions during the expected fourth-quarter closing period.
  • Freddie expects substantial annual revenue and adjusted EBITDA, although those target-company forecasts are not completed financial results yet.
  • Grindr raised annual revenue guidance after second-quarter growth and expects the acquisition’s current-year financial effect to remain immaterial.

A proposed telehealth acquisition would extend Grindr Inc. (NYSE:GRND) beyond its existing social networking and dating platform. The company agreed on 30 September 2026 to acquire PurposeMed, parent of HIV prevention care provider Freddie, for USD 250 million in cash and stock. A further earn-out could increase cash consideration if future performance conditions are met.

Cash and Shares Form the Initial Consideration

The agreement provides for USD 190 million in cash and USD 60 million in Grindr common stock. It also includes up to USD 70 million in cash tied to 2027 performance targets and payable in 2028.

The earn-out is conditional. It should not be described as an amount already paid or certain to be paid, because its value depends on the future targets being achieved.

Both boards have approved the agreement. Closing is expected in the fourth quarter of 2026, subject to customary conditions. Board approval is therefore a completed step, while completion of the purchase remains pending in the supplied material.

Freddie Brings a Different Service Model

Founded in Canada in 2020, Freddie provides telehealth HIV prevention care across all 50 US states and five Canadian provinces. It has served more than 55,000 patients, according to the transaction announcement.

The target expects 2026 revenue above USD 80 million and adjusted EBITDA above USD 10 million. These figures are management expectations for the target business, rather than audited outcomes already achieved for the year.

Grindr operates a social networking and dating app for LGBTQ+ communities through a free advertising-supported version and a paid premium tier. The proposed purchase consequently adds a healthcare activity to an existing app-based business, while integration and completion remain future tasks.

Current-Year Effect Expected to Be Limited

Grindr expects the acquisition’s effect on its 2026 results to be immaterial. It said it would provide its 2027 outlook during the third-quarter earnings call in November.

The material also does not disclose Grindr’s cash balance or specify how the USD 190 million cash component will be funded. The transaction terms establish the amount of initial cash consideration, but not the complete financing arrangements or the final post-closing balance sheet.

Quarterly Growth Precedes the Purchase

Grindr reported second-quarter 2026 results on 6 August. Revenue reached USD 138 million, up 33%, while adjusted EBITDA was USD 58 million, compared with USD 45 million a year earlier.

The adjusted EBITDA margin was 42%. Management raised 2026 revenue guidance to USD 540 million. That figure remains a forecast, distinct from the completed second-quarter revenue result and Freddie’s own expected annual revenue.

The supplied material identifies regulatory, privacy and clinical-operations obligations as relevant to the healthcare expansion. It does not quantify future compliance costs or establish that integration has already been completed.

The next transaction milestone is satisfaction of closing conditions. Subsequent company disclosure would be needed to establish completion, financing details and the 2027 outlook. Performance against the earn-out targets will concern a later period and should remain separate from the initial purchase consideration and current-year guidance.